Company page
Cellromax Science Co., Ltd.
Cellromax Science Co., Ltd. is a public company listed under the ticker 471820, operating in the South Korean market. The company has a market capitalization of approximately 32.32 million USD. Cellromax focuses on innovative solutions within its industry, contributing to advancements in technology and science.
- Ticker
- 471820:KRX
- Asset type
- Stock
- Market cap
- $32.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- KRX
- Currency
- KRW